FDA Drug Application (206843) for DAKLINZA by BRISTOL-MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL-MYERS SQUIBB

Application Number206843
Product Number001
FormTABLET;ORAL
DosageEQ 30MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDAKLINZA
Active IngredientDACLATASVIR DIHYDROCHLORIDE



Back to FDA Applications sponsored by BRISTOL-MYERS SQUIBB